Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03123939
Title Phase III B in Acute Lymphoblastic Leukemia
Recruitment Completed
Gender
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child | adult
Covered Countries NOR | ITA | FRA | ESP | DEU | CAN | BEL | AUT

Facility Status City State Zip Country Details
Novartis Investigative Site Wien A 1090 Austria Details
Novartis Investigative Site Gent 9000 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 1X8 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1C5 Canada Details
Novartis Investigative Site Paris Cedex 10 75475 France Details
Novartis Investigative Site Paris Cedex 75019 France Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Kyoto 606 8507 Japan Details
Novartis Investigative Site Oslo 0424 Norway Details
Novartis Investigative Site Esplugues de Llobregat Barcelona 08950 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field